Bristol-Myers Squibb | BMY - Eigenkapital Und Reserven

Aktienkurs
59.37
Täglich Wechseln
-0.34 -0.57%
Monatlich
-1.54%
Jährlich
-1.18%
Q1 Prognose
57.30




Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -3.27B 628M 2025-12
Abbott USD 52.13B 1.3B 2025-12
ALKERMES USD 1.82B 85.86M 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Biogen USD 18.21B 573.5M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Coherus Biosciences USD 61.01M 26.76M 2025-12
Drreddys Laboratories INR 4.14B 107.72M 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
J&J USD 78.47B 0 2025-09
Medtronic USD 48.86B 964M 2025-09
Merck USD 51.85B 2.79B 2025-09
Novartis USD 44.75B 2.7B 2025-09
Novo Nordisk DKK 194.05B 24.15B 2025-12
Perrigo USD 2.94B 1.51B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Phibro Animal Health USD 332.36M 20.68M 2025-12
Prestige Brands USD 1.83B 4.48M 2025-12
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 71.71B 1.55B 2025-12
Sanofi EUR 71.71B 14.25B 2025-12
United Therapeutics USD 7.1B 506M 2025-12
Zoetis USD 3.33B 2.07B 2025-12